Mantle Cell Lymphoma
Mantle Cell Lymphoma
The latest news, research, and perspectives in mantle cell lymphoma (MCL). In MCL, a malignant B lymphocyte in the outer edge, or mantle zone, of a lymph node follicle grows uncontrollably, resulting in the accumulation of lymphoma cells.
Advertisement
Melissa BadamoAcute Lymphoblastic Leukemia | May 16, 2025
Studies have shown that oncologists are leaving the workforce at increasing rates in association with growing workloads.
Read More
Melissa BadamoAcute Lymphoblastic Leukemia | May 8, 2025
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
Nirav Shah, MD, MSHPMantle Cell Lymphoma | May 8, 2025
Nirav Shah, MD, MSHP, tells BCT about his team's phase I/II clinical trial findings.
Andrew MorenoAggressive B-Cell Lymphoma | April 30, 2025
Efficacy and safety profile data were presented at the AACR Annual Meeting 2025.
Andrew MorenoTransplantation & Cellular Therapy | April 25, 2025
The ASCO Association Board Chair has written letters to the new heads of the CMS, FDA, and NIH.
Melissa BadamoAcute Lymphoblastic Leukemia | April 23, 2025
The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.
Melissa BadamoMantle Cell Lymphoma | April 15, 2025
Tycel Phillips, MD, discussed his presentation on BTK inhibitors from the International Ultmann Chicago Lymphoma Symposium.
Nirav Shah, MD, MSHPTransplantation & Cellular Therapy | April 15, 2025
Nirav Shah, MD, MSHP, recently presented at the International Ultmann Chicago Lymphoma Symposium on this subject.
Melissa BadamoVideo Insights | April 15, 2025
Nicholas Freedman, DO, presented on symptom management and supportive care at the Tri-State Blood Cancer Conference.
Melissa BadamoAcute Lymphoblastic Leukemia | April 8, 2025
More than 240 meetings were held with members of Congress as part of the ASCO 10th Annual Advocacy Summit.
Nichole TuckerAggressive B-Cell Lymphoma | April 1, 2025
Machine learning may aid point-of-care clinical decision-making for NHL patients receiving CAR T-cell therapy.
Melissa BadamoMantle Cell Lymphoma | April 8, 2025
Martin Dreyling, MD, discusses the TRIANGLE study and the shifting roles of autologous HSCT and chemotherapy in MCL.
Melissa BadamoAcute Lymphoblastic Leukemia | March 14, 2025
Melody Smith, MD, MS, shares data on burnout in hematologist oncologists, why it occurs, and how to prevent it.
Andrew MorenoAggressive B-Cell Lymphoma | March 14, 2025
A panel moderated by Neil Love, MD, explored clinical data to assess these treatment approaches for the various types of NHL.
Andrew MorenoFollicular Lymphoma | February 26, 2025
Clinical evaluations of this bispecific antibody as monotherapy or in polytherapy for B-cell non-Hodgkin lymphomas continue.
Andrew MorenoFollicular Lymphoma | March 14, 2025
This new approval adds upon the agent's indications for relapsed or refractory DLBCL and other large B-cell lymphomas.
Melissa BadamoMantle Cell Lymphoma | February 21, 2025
Dr. Phillips discussed the phase II TRIANGLE study, the shifting role of HSCT, and unmet needs in high-risk patients.
Melissa BadamoMantle Cell Lymphoma | February 19, 2025
CAR22 therapy demonstrated an ORR of 100% and a complete response rate of 83% in six patients with MCL or FL.
Andrew MorenoAggressive B-Cell Lymphoma | March 14, 2025
Approved for adults ineligible for autologous transplant or CAR T-cell therapy following at least two systemic therapies.
Blood Cancer TalksChronic Lymphocytic Leukemia | January 31, 2025
David Russler-Germain, MD, PhD, joins the hosts of “Blood Cancer Talks” to highlight research in lymphoma and CLL.
Advertisement
Advertisement